Počet záznamov: 1
Disulfiram overcomes cisplatin resistance in human embryonal carcinoma cells
Názov Disulfiram overcomes cisplatin resistance in human embryonal carcinoma cells Autor Schmidtová Silvia SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV RID ORCID Spoluautori Kaľavská Katarína 1987- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Gerčáková Katarína SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Čierna Zuzana Miklíková Svetlana 1988- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS ORCID Smolková Božena 1968- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS RID ORCID Buociková Verona SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Miškovská V. Ďuriníková Erika 1988- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ORCID Buríková Monika SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Chovanec Michal Matúšková Miroslava 1977- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV ORCID Mego Michal Kučerová Lucia 1973- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV Zdroj.dok. Cancers. Vol. 11 (2019), art.no. 1224 Jazyk dok. eng - angličtina Poznámky open access URL URL link Druh dok. rozpis článkov z periodík (rbx) Ohlasy CHIEFFI, Paolo - DE MARTINO, Marco - ESPOSITO, Francesco. Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets. In EXPERT REVIEW OF ANTICANCER THERAPY. ISSN 1473-7140, 2020, vol. 20, no. 3, pp. 189-195. KANNAPPAN, V. - ALI, M. - SMALL, B. - RAJENDRAN, G. - ELZHENNI, S. - TAJ, H. - WANG, W.G. - DOU, Q.P. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents. In FRONTIERS IN MOLECULAR BIOSCIENCES. SEP 17 2021, vol. 8. READ, E. - MILFORD, J. - ZHU, J.C. - WU, L.Y. - BILODEAU, M. - YANG, G.D. The interaction of disulfiram and H2S metabolism in inhibition of aldehyde dehydrogenase activity and liver cancer cell growth. In TOXICOLOGY AND APPLIED PHARMACOLOGY. ISSN 0041-008X, SEP 1 2021, vol. 426. ICARD, P. - LOI, M. - WU, Z.R. - GINGUAY, A. - LINCET, H. - ROBIN, E. - COQUEREL, A. - BERZAN, D. - FOURNEL, L. - ALIFANO, M. Metabolic Strategies for Inhibiting Cancer Development. In ADVANCES IN NUTRITION. ISSN 2161-8313, JUL 2021, vol. 12, no. 4, p. 1461-1480. PINTO, M.T. - CARCANO, F.M. - VIEIRA, A.G.S. - CABRAL, E.R.M. - LOPES, L.F. Molecular Biology of Pediatric and Adult Male Germ Cell Tumors. In CANCERS. MAY 2021, vol. 13, no. 10. KAUL, L. - SUSS, R. - ZANNETTINO, A. - RICHTER, K. The revival of dithiocarbamates: from pesticides to innovative medical treatments. In ISCIENCE. FEB 19 2021, vol. 24, no. 2. LU, C. - LI, X.Y. - REN, Y.Y. - ZHANG, X. Disulfiram: a novel repurposed drug for cancer therapy. In CANCER CHEMOTHERAPY AND PHARMACOLOGY. ISSN 0344-5704, FEB 2021, vol. 87, no. 2, p. 159-172. HUANG, X. - HOU, Y.C. - WENG, X.L. - PANG, W.J. - HOU, L.D. - LIANG, Y. - WANG, Y. - DU, L.L. - WU, T.Q. - YAO, M.F. - WANG, J.H. - MENG, X.J. Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway. In ONCOGENESIS. ISSN 2157-9024, JAN 8 2021, vol. 10, no. 1. NAMEKAWA, T. - KITAYAMA, S. - IKEDA, K. - HORIE-INOUE, K. - SUZUKI, T. - OKAMOTO, K. - ICHIKAWA, T. - YANO, A. - KAWAKAMI, S. - INOUE, S. HIF1 alpha inhibitor 2-methoxyestradiol decreases NRN1 expression and represses in vivo and in vitro growth of patient-derived testicular germ cell tumor spheroids. In CANCER LETTERS. ISSN 0304-3835, OCT 1 2020, vol. 489, p. 79-86. DE VRIES, G. - ROSAS-PLAZA, X. - VAN VUGT, M.A.T.M. - GIETEMA, J.A. - DE JONG, S. Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities. In CANCER TREATMENT REVIEWS. ISSN 0305-7372, AUG 2020, vol. 88. LOBO, J. - JERONIMO, C. - HENRIQUE, R. Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives. In CANCERS. JUN 2020, vol. 12, no. 6. RIEBER, M. Cancer Pro-oxidant Therapy through Copper Redox Cycling: Repurposing Disulfiram and Tetrathiomolybdate. In CURRENT PHARMACEUTICAL DESIGN. ISSN 1381-6128, 2020, vol. 26, no. 35, p. 4461-4466. ZHONG, S.Y. - LIU, S.Y. - SHI, X. - ZHANG, X.D. - LI, K.H. - LIU, G.J. - LI, L.S. - TAO, S.W. - ZHENG, B.W. - SHENG, W.C. - YE, Z.Y. - XING, Q.C. - ZHAI, Q.Q. - REN, L.J. - WU, Y. - BAO, Y.J. Disulfiram in glioma: Literature review of drug repurposing. In FRONTIERS IN PHARMACOLOGY. AUG 24 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fphar.2022.933655. HENDRYCH, M. - RíHOVá, K. - ADAMOVá, B. - HRADIL, V. - STIBOREK, M. - VLCEK, P. - HERMANOVá, M. - VASíCKOVá, J. - BENES, P. - SMARDA, J. - KANICKY, V. - PREISLER, J. - NAVRáTILOVá, J. Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma. In BIOMEDICINE & PHARMACOTHERAPY. ISSN 0753-3322, SEP 2022, vol. 153. Dostupné na: https://doi.org/10.1016/j.biopha.2022.113465. ALMEIDA-SILVA, J. - MENEZES, D.S. - FERNANDES, J.M.P. - ALMEIDA, M.C. - VASCO-DOS-SANTOS, D.R. - SARAIVA, R.M. - VIçOSA, A.L. - PEREZ, S.A.C. - ANDRADE, S.G. - SUAREZ-FONTES, A.M. - VANNIER-SANTOS, M.A. The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance. In FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. ISSN 2235-2988, JUL 29 2022, vol. 12. Dostupné na: https://doi.org/10.3389/fcimb.2022.926699. LU, Y. - PAN, Q.Q. - GAO, W.X. - PU, Y.J. - LUO, K. - HE, B. - GU, Z.W. Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens. In BIOMATERIALS. ISSN 0142-9612, FEB 2022, vol. 281. Dostupné na: https://doi.org/10.1016/j.biomaterials.2021.121335. SUN, F.L. - WANG, H.Z. - NIE, J.F. - HONG, B. Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and Mechanisms. In ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. ISSN 1871-5206, 2022, vol. 22, no. 17, p. 2920-2926. Dostupné na: https://doi.org/10.2174/1871520621666220415102553. Kategória ADMA - Vedecké práce v zahraničných impaktovaných časopisoch registrovaných vo WOS Core Collection alebo SCOPUS Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2019 Registrované v WOS Registrované v SCOPUS DOI 10.3390/cancers11091224 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Disulfiram overcomes cisplatin resistance in human embryonal carcinoma cells.pdf Prístupný 3.1 MB 0 Vydavateľská verzia rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore N rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2019 2018 6.162 Q1 2.142 Q1
Počet záznamov: 1